tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Exagen reports preliminary Q4 revenue $16M-$17M, consensus $17.19M
PremiumThe FlyExagen reports preliminary Q4 revenue $16M-$17M, consensus $17.19M
1M ago
Exagen price target lowered to $13 from $18 at TD Cowen
Premium
The Fly
Exagen price target lowered to $13 from $18 at TD Cowen
1M ago
Exagen’s Strategic Growth and Innovation Drive Buy Rating Amid Market Expansion
Premium
Ratings
Exagen’s Strategic Growth and Innovation Drive Buy Rating Amid Market Expansion
3M ago
Exagen’s Earnings Call: Growth Amid Financial Hurdles
PremiumCompany AnnouncementsExagen’s Earnings Call: Growth Amid Financial Hurdles
3M ago
Exagen’s Growth Potential Amid ASP Challenges: A Positive Long-Term Investment Outlook
Premium
Ratings
Exagen’s Growth Potential Amid ASP Challenges: A Positive Long-Term Investment Outlook
3M ago
Exagen’s Strong Volume Growth and Market Penetration Support Buy Rating Despite Temporary ASP Setbacks
Premium
Ratings
Exagen’s Strong Volume Growth and Market Penetration Support Buy Rating Despite Temporary ASP Setbacks
3M ago
Exagen price target raised to $15 from $12 at KeyBanc
PremiumThe FlyExagen price target raised to $15 from $12 at KeyBanc
4M ago
Exagen initiated with a Buy at B. Riley
Premium
The Fly
Exagen initiated with a Buy at B. Riley
5M ago
Exagen’s Legal Challenges: Potential Risks to Financial Stability and Market Position
Premium
Company Announcements
Exagen’s Legal Challenges: Potential Risks to Financial Stability and Market Position
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100